Literature DB >> 21706129

Production of classical swine fever virus envelope glycoprotein E2 as recombinant polyhedra in baculovirus-infected silkworm larvae.

Kwang Sik Lee1, Mi Ri Sohn, Bo Yeon Kim, Young Moo Choo, Soo Dong Woo, Sung Sik Yoo, Yeon Ho Je, Jae Young Choi, Jong Yul Roh, Hyun Na Koo, Byung Rae Jin.   

Abstract

Although, classical swine fever virus (CSFV) envelope glycoprotein E2 subunit vaccine has been developed using the baculovirus expression system, the expression of viral antigens in baculovirus-infected insect cells is often ineffective. Therefore, an alternative strategy to the traditional baculovirus expression system is needed that is more productive and effective. Here, we report a novel strategy for the large-scale production of a CSFV E2 in the larvae of a baculovirus-infected silkworm, Bombyx mori. We constructed a recombinant B. mori nucleopolyhedrovirus (BmNPV) that expressed recombinant polyhedra together with the N-terminal 179 amino acids of CSFV E2 (E2ΔC). BmNPV-E2ΔC-infected silkworm larvae expressed native polyhedrin and approximately 44-kDa fusion protein that was detected using both anti-polyhedrin and anti-CSFV E2 antibodies. Electron and confocal microscopy both demonstrated that the recombinant polyhedra contained both the fusion protein and native polyhedrin were morphologically normal and contained CSFV E2ΔC. The CSFV E2ΔC antigen produced in BmNPV-E2ΔC-infected silkworm larvae reached 0.68 mg/ml of hemolymph and 0.53 mg/larva at 6-days post-infection. Six-week-old female BALB/c mice that were immunized with the E2ΔC protein purified from solubilized recombinant polyhedra elicited CSFV E2 antibodies, which indicated that the CSFV E2ΔC protein from recombinant polyhedra was immunogenic. The virus neutralization test showed that the serum from mice that were treated with E2ΔC protein from recombinant polyhedra contained significant levels of virus neutralization activity. These results demonstrate that this strategy can be used for the large-scale production of CSFV E2 antigen.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21706129     DOI: 10.1007/s12033-011-9431-5

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  30 in total

1.  An experimental infection with classical swine fever in E2 sub-unit marker-vaccine vaccinated and in non-vaccinated pigs.

Authors:  J Dewulf; H Laevens; F Koenen; H Vanderhallen; K Mintiens; H Deluyker; A de Kruif
Journal:  Vaccine       Date:  2000-10-15       Impact factor: 3.641

Review 2.  Expression of foreign genes in insects using baculovirus vectors.

Authors:  S Maeda
Journal:  Annu Rev Entomol       Date:  1989       Impact factor: 19.686

3.  Vaccination with a single dose of a recombinant porcine adenovirus expressing the classical swine fever virus gp55 (E2) gene protects pigs against classical swine fever.

Authors:  J M Hammond; R J McCoy; E S Jansen; C J Morrissy; A L Hodgson; M A Johnson
Journal:  Vaccine       Date:  2000-01-06       Impact factor: 3.641

4.  Classical swine fever virus (CSFV) envelope glycoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challenge.

Authors:  P A van Rijn; A Bossers; G Wensvoort; R J Moormann
Journal:  J Gen Virol       Date:  1996-11       Impact factor: 3.891

5.  Baculovirus surface display of E2 envelope glycoprotein of classical swine fever virus and immunogenicity of the displayed proteins in a mouse model.

Authors:  Xin-Gang Xu; Hung-Jen Liu
Journal:  Vaccine       Date:  2008-08-15       Impact factor: 3.641

6.  Early onset and long lasting protection in pigs provided by a classical swine fever E2-vaccine candidate produced in the milk of goats.

Authors:  Maritza Barrera; Oliberto Sánchez; Omar Farnós; María P Rodríguez; Patricia Domínguez; Henry Tait; María Frías; Mislay Avila; Ernesto Vega; Jorge R Toledo
Journal:  Vet Immunol Immunopathol       Date:  2009-06-30       Impact factor: 2.046

7.  Immune responses induced by a BacMam virus expressing the E2 protein of classical swine fever virus in mice.

Authors:  Miao Li; Yu-Fei Wang; Yu Wang; Hui Gao; Na Li; Yuan Sun; Bing-Bing Liang; Hua-Ji Qiu
Journal:  Immunol Lett       Date:  2009-07-07       Impact factor: 3.685

8.  Highly protective E2-CSFV vaccine candidate produced in the mammary gland of adenoviral transduced goats.

Authors:  Jorge R Toledo; Oliberto Sánchez; Raquel Montesino; Omar Farnos; Maria P Rodríguez; Pastor Alfonso; Nayrobis Oramas; Elsa Rodríguez; Elaine Santana; Ernesto Vega; Llilianne Ganges; Maria T Frias; José Cremata; Maritza Barrera
Journal:  J Biotechnol       Date:  2007-10-05       Impact factor: 3.307

Review 9.  Silkworm expression system as a platform technology in life science.

Authors:  Tatsuya Kato; Mizuho Kajikawa; Katsumi Maenaka; Enoch Y Park
Journal:  Appl Microbiol Biotechnol       Date:  2010-01       Impact factor: 4.813

10.  Comparison of antibody values in sera of pigs vaccinated with a subunit or an attenuated vaccine against classical swine fever.

Authors:  S Terzić; L Jemersić; M Lojkić; J Madić; J Grom; I Toplak; L Sver; I Valpotić
Journal:  Vet Res Commun       Date:  2003-05       Impact factor: 2.816

View more
  3 in total

1.  Identification of fragments from Autographa californica polyhedrin protein essential for self-aggregation and exogenous protein incorporation.

Authors:  Alicia Sampieri; Agustín Luz-Madrigal; Jesus Zepeda; Luis Vaca
Journal:  BMC Biochem       Date:  2015-02-04       Impact factor: 4.059

2.  Protein composition analysis of polyhedra matrix of Bombyx mori nucleopolyhedrovirus (BmNPV) showed powerful capacity of polyhedra to encapsulate foreign proteins.

Authors:  Zhong-Jian Guo; Meng-Han Yu; Xian-Yun Dong; Wei-Li Wang; Ting Tian; Xian-Yin Yu; Xu-Dong Tang
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

3.  A baculovirus-mediated strategy for full-length plant virus coat protein expression and purification.

Authors:  Daniel Mendes Pereira Ardisson-Araújo; Juliana Ribeiro Rocha; Márcio Hedil Oliveira da Costa; Anamélia Lorenzetti Bocca; André Nepomuceno Dusi; Renato de Oliveira Resende; Bergmann Morais Ribeiro
Journal:  Virol J       Date:  2013-08-15       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.